Treatment of Rhinovirus Infection
Rhinovirus infection should be managed with symptomatic treatment only—antibiotics are not indicated, and no specific antiviral therapy is currently approved or recommended. 1, 2
Core Management Approach
Rhinovirus causes viral rhinosinusitis (VRS), a self-limited illness that typically peaks within 3 days and resolves within 10-14 days without specific treatment. The primary goal is symptomatic relief while avoiding unnecessary antibiotic use, which provides no benefit for viral illness and contributes to antimicrobial resistance.
First-Line Symptomatic Therapies
Recommended options include:
Non-narcotic analgesics: Acetaminophen or NSAIDs (ibuprofen) for pain, fever, and discomfort 1, 2
- Acetaminophen helps with nasal obstruction and rhinorrhea but not sore throat or malaise
- NSAIDs improve malaise, sneezing, headache, and otalgia but not nasal discharge
- Use NSAIDs cautiously in older adults due to comorbidities
Nasal saline irrigation: Physiologic or hypertonic solutions provide minor symptom improvement with minimal risk 1, 2
- Higher volume irrigations may be superior
- Safe, cleansing, and palliative
Intranasal corticosteroids: May provide symptomatic relief for congestion and rhinorrhea 1
Decongestants: Use With Caution
Topical decongestants (oxymetazoline):
- May be beneficial for up to 3-5 days maximum 2
- Critical warning: Do not exceed 3-5 days to avoid rebound congestion (rhinitis medicamentosa) 1, 2
Oral decongestants:
- The FDA advisory committee (2023) discouraged oral phenylephrine as ineffective 2
- Pseudoephedrine could be considered but has limited recent evidence and requires counseling about:
- Contraindications: hypertension, elevated heart rate
- "Behind the counter" access restrictions
What NOT to Use
Oral antihistamines: Show no clinical benefit for viral rhinosinusitis and are not recommended 3, 2
Antibiotics: Absolutely contraindicated for uncomplicated rhinovirus infection 1, 2
- Antibiotics are ineffective against viral illness
- Reserve for suspected bacterial superinfection only (see below)
Distinguishing Viral from Bacterial Infection
Suspect bacterial rhinosinusitis (requiring antibiotics) only when:
- Symptoms persist ≥7 days with purulent nasal discharge PLUS maxillary tooth pain or unilateral facial pain 4
- Unilateral sinus tenderness present 4
- Worsening symptoms after initial improvement ("double-worsening") 4
- Severe symptoms from onset 4
Key distinction: Patients with symptoms <7 days are unlikely to have bacterial infection 4. Discolored nasal discharge alone does NOT indicate bacterial infection—it reflects neutrophil presence from inflammation, not bacteria 1, 2.
When to Escalate Care
Refer to allergist/immunologist if: 3
- Prolonged symptoms beyond expected 10-14 day course
- Complications develop (otitis media, sinusitis, nasal polyposis)
- Comorbid asthma or chronic sinusitis
- Significant quality of life impairment
- Treatment failure or medication adverse effects
Consider bacterial superinfection requiring antibiotics if:
- Symptoms meet criteria above (≥7 days, specific pain patterns, double-worsening)
- Use narrow-spectrum agents: amoxicillin, doxycycline, or trimethoprim-sulfamethoxazole targeting Streptococcus pneumoniae and Haemophilus influenzae 4
Special Populations
High-risk patients (immunocompromised, hematopoietic stem cell transplant recipients, severe comorbidities) may experience severe complications 5, 6. These patients warrant closer monitoring, but specific antiviral therapy for rhinovirus remains unavailable in routine clinical practice 7, 8, 9, 10, 11.
Patients with comorbidities (pulmonary disease, malignancy, diabetes) face increased risk of lower respiratory tract infection, hospitalization, and mortality 6. Maintain heightened clinical vigilance but treatment remains supportive.
Clinical Pitfalls to Avoid
Do not prescribe antibiotics for discolored nasal discharge alone—this is inflammation, not bacterial infection 1, 2
Do not use topical decongestants beyond 3-5 days—rebound congestion is a real and problematic complication 1, 2
Do not rely on oral phenylephrine—FDA evidence shows it is ineffective 2
Do not order imaging for uncomplicated cases—sinus radiography has high false-positive rates in viral rhinosinusitis 4
Educate patients about the self-limited nature of rhinovirus infection and provide clear return precautions for worsening symptoms 4